BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice

References

• Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–172.
   PubMed Web of Science ®Google Scholar
• Lunn JS, Sakowski SA, Feldman EL. Concise review: stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future. Stem Cells. 2014;32:1099–1109.
   PubMed Web of Science ®Google Scholar
• Ciervo Y, Ning K, Jun X, et al. Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis. Mol Neurodegener. 2017;12:85.
   PubMed Web of Science ®Google Scholar
• Gouel F, Rolland AS, Devedjian JC, et al. Past and Future of Neurotrophic Growth Factors Therapies in ALS: from Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates. Front Neurol. 2019;10:835.
   PubMed Web of Science ®Google Scholar
• Lunn JS, Hefferan MP, Marsala M, et al. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. Growth Factors. 2009;27:133–140.
   PubMed Web of Science ®Google Scholar
• Wang J, Hu WW, Jiang Z, et al. Advances in treatment of neurodegenerative diseases: perspectives for combination of stem cells with neurotrophic factors. World J Stem Cells. 2020;12:323–338.
   PubMed Web of Science ®Google Scholar
• Ochs G, Penn RD, York M, et al. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:201–206.
   PubMed Web of Science ®Google Scholar
• Hu W, Feng Z, Xu J, et al. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer’s disease rats. Brain Res. 2019;1710:61–73.
   PubMed Web of Science ®Google Scholar
• Zhao C, Li H, Zhao XJ, et al. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson’s disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons. Neurochem Res. 2016;41:1238–1249.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang D, Qiao T, et al. A single injection of recombinant adeno-associated virus into the lumbar cistern delivers transgene expression throughout the whole spinal cord. Mol Neurobiol. 2016;53:3235–3248.
   PubMed Web of Science ®Google Scholar
• Cleveland DW, Rothstein JD. From charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci. 2001;2:806–819.
   PubMed Web of Science ®Google Scholar
• Baloh RH, Glass JD, Svendsen CN. Stem cell transplantation for amyotrophic lateral sclerosis. Curr Opin Neurol. 2018;31:655–661.
   PubMed Web of Science ®Google Scholar
• Deng P, Anderson JD, Yu AS, et al. Engineered BDNF producing cells as a potential treatment for neurologic disease. Expert Opin Biol Ther. 2016;16:1025–1033.
   PubMed Web of Science ®Google Scholar
• Thomsen GM, Avalos P, Ma AA, et al. Transplantation of neural progenitor cells expressing glial cell line-derived neurotrophic factor into the motor cortex as a strategy to treat amyotrophic lateral sclerosis. Stem Cells. 2018;36:1122–1131.
   PubMed Web of Science ®Google Scholar
• Suzuki M, McHugh J, Tork C, et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther. 2008;16:2002–2010.
   PubMed Web of Science ®Google Scholar
• Hwang DH, Lee HJ, Park IH, et al. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther. 2009;16:1234–1244.
   PubMed Web of Science ®Google Scholar
• Krakora D, Mulcrone P, Meyer M, et al. Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol Ther. 2013;21:1602–1610.
   PubMed Web of Science ®Google Scholar
• Dadon-Nachum M, Ben-Yaacov K, Ben-Zur T, et al. Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALS. J Mol Neurosci. 2015;55:788–797.
   PubMed Web of Science ®Google Scholar
• Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–349.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci. 2013;7:253.
   PubMed Web of Science ®Google Scholar
• Gruzman A, Wood WL, Alpert E, et al. Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2007;104:12524–12529.
   PubMed Web of Science ®Google Scholar
• Bosco DA, Morfini G, Karabacak NM, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13:1396–1403.
   PubMed Web of Science ®Google Scholar
• Forsberg K, Jonsson PA, Andersen PM, et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One. 2010;5:e11552.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Homma K, Ichijo H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul. 2016;60:95–104.
   PubMedGoogle Scholar
• van Zundert B, Brown RH Jr. Silencing strategies for therapy of SOD1-mediated ALS. Neurosci Lett. 2017;636:32–39.
   PubMed Web of Science ®Google Scholar
• Thomsen GM, Gowing G, Latter J, et al. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J Neurosci. 2014;34:15587–15600.
   PubMed Web of Science ®Google Scholar
• Elmer BM, McAllister AK. Major histocompatibility complex class I proteins in brain development and plasticity. Trends Neurosci. 2012;35:660–670.
   PubMed Web of Science ®Google Scholar
• Huh GS, Boulanger LM, Du H, et al. Functional requirement for class I MHC in CNS development and plasticity. Science. 2000;290:2155–2159.
   PubMed Web of Science ®Google Scholar
• Goddard CA, Butts DA, Shatz CJ. Regulation of CNS synapses by neuronal MHC class I. Proc Natl Acad Sci U S A. 2007;104:6828–6833.
   PubMed Web of Science ®Google Scholar
• Boulanger LM. Immune proteins in brain development and synaptic plasticity. Neuron. 2009;64:93–109.
   PubMed Web of Science ®Google Scholar
• Freria CM, Zanon RG, Santos LM, et al. Major histocompatibility complex class I expression and glial reaction influence spinal motoneuron synaptic plasticity during the course of experimental autoimmune encephalomyelitis. J Comp Neurol. 2010;518:990–1007.
   PubMed Web of Science ®Google Scholar
• Kassa RM, Bonafede R, Boschi F, et al. The role of mutated SOD1 gene in synaptic stripping and MHC class I expression following nerve axotomy in ALS murine model. Eur J Histochem. 2018;62:2904.
   PubMed Web of Science ®Google Scholar
• Nardo G, Iennaco R, Fusi N, et al. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. Brain. 2013;136:3305–3332.
   PubMed Web of Science ®Google Scholar
• Tay CH, Szomolanyi-Tsuda E, Welsh RM. Control of infections by NK cells. Curr Top Microbiol Immunol. 1998;230:193–220.
   PubMed Web of Science ®Google Scholar
• Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 1999;17:875–904.
   PubMed Web of Science ®Google Scholar
• Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225–274.
   PubMed Web of Science ®Google Scholar
• Song S, Miranda CJ, Braun L, et al. Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nat Med. 2016;22:397–403.
   PubMed Web of Science ®Google Scholar